Stockreport

Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma, Ltd. Investors

Quantum Biopharma Ltd. - Class B Subordinate Voting Shares  (QNTM) 
PDF LOS ANGELES, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Quantum Biopharma, Ltd., (“Quantum” or the "Company") (NASDAQ: QNTM) investors of a class a [Read more]